bioRxivMicrobiology
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines
I. del Moral-Sanchez, E. G. Wee, Y. Xian, W.-H. Lee, J. D. Allen, A. Torrents de la Pena, R. d. P. F. Rocha, J. Ferguson, A. N. Leon, S. Koekkoek, E. E. Schermer, J. A. Burger, S. Kumar, R. Zwolsman, M. Brinkkemper, A. Aartse, D. Eggink, J. Han, M. Yuan, M. Crispin, G. Ozorowski, A. B. Ward, I. A. Wilson, T. Hanke, K. Sliepen, R. W. Sanders
Abstract
Recombinant native-like HIV-1 envelope glycoprotein (Env) trimers are used in candidate vaccines aimed at inducing broadly neutralizing antibodies. While state-of-the-art SOSIP or single-chain Env designs can be expressed as native-like trimers, undesired monomers, dimers and malformed trimers that elicit non-neutralizing antibodies are also formed, implying that these designs could benefit from further modifications for gene-based vaccination approaches. Here, we describe the triple tandem trimer (TTT) design in which three Env protomers are genetically linked in a single open reading frame and express as native-like trimers. Viral vectored Env TTT induced similar neutralization titers but with a higher proportion of trimer-specific responses. The TTT design was also applied to generate influenza hemagglutinin (HA) trimers without the need for trimerization domains. Additionally, we used TTT to generate well-folded chimeric Env and HA trimers that harbor protomers from three different strains. In summary, the TTT design is a useful platform for the design of HIV-1 Env and influenza HA immunogens for a multitude of vaccination strategies.
- assay: protein structure
- research focus: protein design
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure-guided design of native-like HIV Env Single Chain Trimers for enhanced stability, immunogenicity, and versatile vaccine delivery
Xuduo Li, Ipsita Krishnamurthy, … Raiees Andrabi·bioRxiv·Oct 25, 2025
- Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
A. Antanasijevic, G. Ueda, … A. B. Ward·bioRxiv·Jan 31, 2020
- Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
A. Torrents de la Pena, K. Rantalainen, … A. B. Ward·bioRxiv·Dec 20, 2018
- Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
J. M. Binley, E. Crooks, … L. Verkoczy·bioRxiv·Jul 20, 2021
- Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes
Harry B. Gristick, Harald Hartweger, … Pamela J. Björkman·The Journal of Experimental MedicinePeer-reviewed·Jul 11, 2025
- Structurally related but genetically unrelated antibody lineages converge on an immunodominantHIV-1 Env neutralizing determinant following trimer immunization
S. Aljedani, T. J. Liban, … M. Pancera·bioRxiv·Apr 9, 2021